Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

Frederik Peters; Christina Westphal; Anneke Kramer; Ronny Westerman

首页> 外文期刊>Frontiers in Public Health >Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

【24h】

Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

机译：年龄更大的肾脏替代疗法的普及是长寿的代价吗？

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundRenal replacement therapy (RRT) is one of the most expensive in renal medicine. Cross-sectional studies suggest that life expectancy increases in the general population are associated with a higher burden of RRT. This study tests this hypothesis in a prospective setting among people aged 75+ living in Western Europe.

机译：背景技术肾脏替代疗法（RRT）是肾脏医学中最昂贵的疗法之一。横断面研究表明，普通人群的预期寿命增加与RRT负担增加有关。这项研究在西欧75岁以上的人群中进行了前瞻性的检验。

著录项

来源
《Frontiers in Public Health》 |2018年第2期|共页
作者
Frederik Peters; Christina Westphal; Anneke Kramer; Ronny Westerman;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类个人卫生;
关键词
life expectancyrenal replacement therapyend-stage renal diseaseelderly populationEurope;

机译：预期寿命肾脏替代治疗晚期肾脏疾病老年人口欧洲;

相似文献

外文文献
中文文献
专利

1. Renal replacement therapy for acute renal failure in the intensive care unit is associated with a worse prognosis than renal replacement therapy for end-stage renal failure [J] . M Ostermann, R Chang Critical care : . 2005,第Suppla1期

机译：重症监护病房中用于急性肾衰竭的肾脏替代疗法的预后要比用于终末期肾衰竭的肾脏替代疗法的预后更差
2. Symptom Prevalence and the Negative Emotional States in End-Stage Renal Disease Patients with or without Renal Replacement Therapy: A Cross-Sectional Analysis [J] . Zukiman Wan Zul Haikal Wan, Yaakup Hayati, Zakaria Nor Fadhlina, Journal of palliative medicine . 2017,第10期

机译：症状患病率和终末期肾病患者的负面情绪状态或无肾置换疗法：横截面分析
3. Projecting renal replacement therapy|[ndash]|specific end-stage renal disease prevalence using registry data [J] . Douglas E Schaubel, Howard I Morrison, Stanley S A Fenton Kidney international. . 2000,第S74期

机译：使用注册数据预测肾脏替代治疗|特定疾病终末期肾脏疾病的患病率
4. Improvement in the Quality of Life of Patients with End-Stage Renal Failure Who Live Without Replacement Therapy in Mexico [C] . Ana Paula Pelayo, Montserrat Pelayo, Gabriela Duran-Aguilar International Conference on Human Systems Engineering and Design . 2020

机译：在没有替代疗法的情况下在墨西哥没有替代治疗的患者生活质量的改善
5. Economic evaluation of renal replacement therapies and immunosuppressants of renal transplantation. [D] . Kalo, Zoltan. 2006

机译：肾脏替代疗法和肾脏移植免疫抑制剂的经济评估。
6. Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer? [O] . Frederik Peters, Christina Westphal, Anneke Kramer, 2018

机译：年龄更大的肾脏替代疗法的普及是长寿的代价吗？
7. Dialysis and renal transplantation as renal replacement therapy for end-stage renal failure, with special reference to the ethical problems of living renal donation. [O] . Shoichiro Daimon, Kazushi Dan, Masahiko Okamoto, 2001

机译：透析和肾移植作为肾脏替代治疗终级肾功能衰竭，特别参考生活肾捐款的道德问题。

Is the Rise in the Prevalence of Renal Replacement Therapy at Older Ages the Price for Living Longer?

摘要

著录项

相似文献

相关主题

期刊订阅